CLINICAL_TRIALS
trial_result
· 2021-01-27
Clinical Trial Update: Phase 2b Challenge Study With the Bioconjugate Vaccine Flexyn2a [Phase 2]
Summary
Phase 2b trial of the bioconjugate vaccine Flexyn2a for Shigellosis completed; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: LimmaTech Biologics AG | Conditions: Shigellosis | Phase 2 | Status: COMPLETED | Results posted: 2021-01-27